Neurology/CNS

This segment of NovaMedica’s portfolio currently includes the following products:


Memaneurin – drug for treatment of moderate and severe dementia of Alzheimer’s type, which improves cognitive processes (memory, attention) and increases daily activity.

All products passed Clinical Trials and registered in Russia.

PRODUCTS HAVE CONTRAINDICATIONS. PLEASE CONSULT A SPECIALIST BEFORE USE

Shareholders

Read more

Pipeline

Read more

Media Center

Read more